An investigation on behalf of investors, who currently hold shares of MedAssets, Inc. (NASDAQ:MDAS), was announced concerning whether the takeover of MedAssets, Inc. by Pamplona Capital Management for $31.25 per share is unfair to NASDAQ:MDAS stockholders.
Investors who purchased shares of MedAssets, Inc. (NASDAQ:MDAS) and currently hold any of those NASDAQ:MDAS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain officers and directors of MedAssets, Inc. breached their fiduciary duties owed to NASDAQ:MDAS investors in connection with the proposed acquisition.
On November 2, 2015 MedAssets, Inc. (NASDAQ:MDAS) and Pamplona Capital Management announced that they have entered into an agreement whereby Pamplona will acquire MedAssets, Inc. (NASDAQ:MDAS) for $31.35 per share in cash.
However, the investigation concerns whether the offer is unfair to NASDAQ:MDAS stockholders. More specifically, the investigation concerns whether the MedAssets Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.
On December 1, 2015, shares of MedAssets, Inc. (NASDAQ:MDAS) closed at $30.57 per share.
Those who are current investors in MedAssets, Inc. (NASDAQ:MDAS) shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com